David West, Jr, CEO and Founder of Proscia, discusses a new realm of digital pathology and how it can improve health care for doctors and patients.
Co-Chair Daniel Einhorn, MD, FACP, FACE, talks with fellow Co-Chair Edward Shahady, MD, FAAFP, ABCL about the early results of SGLT2 inhibitors and the cardiovascular benefits and cardiac outcomes.
Bankole A. Johnson, DSc, MD, of the University of Maryland School of Medicine, discusses a recent study on the global disease burden of alcohol and the health risks associated with it.